Oliver Lagore Vanvalin Investment Group Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oliver Lagore Vanvalin Investment Group lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 71.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,694 shares of the medical equipment provider’s stock after buying an additional 1,535 shares during the quarter. Oliver Lagore Vanvalin Investment Group’s holdings in Intuitive Surgical were worth $1,246,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Federated Hermes Inc. lifted its position in Intuitive Surgical by 54.9% during the fourth quarter. Federated Hermes Inc. now owns 242,094 shares of the medical equipment provider’s stock valued at $81,673,000 after buying an additional 85,843 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Intuitive Surgical by 74.6% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 840 shares of the medical equipment provider’s stock worth $283,000 after buying an additional 359 shares during the last quarter. GraniteShares Advisors LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $1,210,000. Everence Capital Management Inc. increased its stake in shares of Intuitive Surgical by 2.3% in the fourth quarter. Everence Capital Management Inc. now owns 9,930 shares of the medical equipment provider’s stock worth $3,350,000 after buying an additional 220 shares during the last quarter. Finally, Main Street Research LLC increased its stake in shares of Intuitive Surgical by 96.6% in the fourth quarter. Main Street Research LLC now owns 73,132 shares of the medical equipment provider’s stock worth $24,672,000 after buying an additional 35,935 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.2 %

Intuitive Surgical stock traded down $0.76 during mid-day trading on Thursday, hitting $373.41. The company’s stock had a trading volume of 1,128,150 shares, compared to its average volume of 1,627,749. The stock has a market capitalization of $132.36 billion, a P/E ratio of 74.39, a P/E/G ratio of 5.88 and a beta of 1.36. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $403.76. The stock’s fifty day moving average price is $387.56 and its two-hundred day moving average price is $342.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The firm had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.89 billion. During the same quarter last year, the business posted $0.91 EPS. The company’s revenue was up 16.6% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Insider Buying and Selling

In related news, VP Marshall Mohr sold 108,790 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, VP Marshall Mohr sold 108,790 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total value of $41,892,853.20. Following the completion of the transaction, the vice president now owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at approximately $736,800. The disclosure for this sale can be found here. In the last 90 days, insiders sold 248,418 shares of company stock valued at $95,927,097. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Piper Sandler lifted their price target on shares of Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 24th. Barclays boosted their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Citigroup boosted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $375.70.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.